Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Facial and Bodily Emotion Recognition in Multiple Sclerosis: The Role of Alexithymia and Other Characteristics of the Disease.
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Directed Differentiation of Oligodendrocyte Progenitor Cells From Mouse Induced Pluripotent Stem Cells.
Drugs that Treat Skin Conditions May Help Combat Multiple Sclerosis.
Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
Prorating WAIS-IV Summary Scores for Patients with Relapsing-Remitting Multiple Sclerosis.
Visualisation of the medial longitudinal fasciculus using fibre tractography in multiple sclerosis patients with internuclear ophthalmoplegia.
Clinicopathological features in anterior visual pathway in neuromyelitis optica.
[Co-authorship and collaboration networks in Spanish research into multiple sclerosis (1996-2010)].
Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis.
Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.
Intra-individual variability in information processing speed reflects white matter microstructure in multiple sclerosis.
Prognostic factors of acute partial transverse myelitis-reply.
Health-related quality of life among latinos with multiple sclerosis.
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy.
Female Gender and Reproductive Factors Affecting Risk, Relapses and Progression in Multiple Sclerosis.
Two-photon imaging of immune cells in neural tissue.
Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.
Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis.
Optic and auditory pathway dysfunction in demyelinating neuropathies.
Factors associated with clinically significant increased walking time in multiple sclerosis: Results of a survival analysis of short-term follow-up data from a clinical database.
Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis.
Multicontrast MR Imaging at 7T in Multiple Sclerosis: Highest Lesion Detection in Cortical Gray Matter with 3D-FLAIR.
Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue.
Pages
« first
‹ previous
…
443
444
445
446
447
448
449
450
451
…
next ›
last »